Henrietta Lacks और HeLa सेल लाइन: नैतिकता, सूचित सहमति और 2026 प्रतिपूर्ति समझौता

Key Insight

2026 में Lacks परिवार का समझौता भारत को जैव‑चिकित्सा अनुसंधान के लिए सहमति नियमों को सख्त करने के लिए मजबूर करता है

Key Facts

1. 1951: Henrietta Lacks' cervical tumour sample was taken at Johns Hopkins Hospital without her informed consent, leading to the creation of the HeLa cell line.
2. HeLa cells are the first immortal human cell line and have underpinned the development of vaccines, cancer therapies, and genomic research.
3. 2026: After 75 years of advocacy, the Lacks family reached a financial settlement with Johns Hopkins, acknowledging the breach of informed consent.
4. The 2026 settlement requires the Lacks family’s participation in decision‑making and credit attribution for any future HeLa‑based research.
5. The case prompted revisions to the US ‘Common Rule’ (2023) and India’s ICMR ethical guidelines (2025) to tighten bioethics and patient‑rights safeguards.
6. The episode highlights the constitutional right to privacy and bodily autonomy under Article 21 of the Indian Constitution.
7. Rebecca Skloot’s 2010 book “The Immortal Life of Henrietta Lacks” brought global attention to the ethical lapses surrounding the HeLa line.

Background

HeLa कथा वैज्ञानिक प्रगति और व्यक्तिगत अधिकारों के टकराव को दर्शाती है, जो GS4 (नैतिकता) और GS3 (विज्ञान एवं प्रौद्योगिकी) का मुख्य विषय है। यह GS2 (राजनीति) में संस्थागत जवाबदेही और अनुसंधान शासन में मजबूत सहमति ढाँचों की आवश्यकता पर चर्चा को भी सूचित करती है।

UPSC Syllabus

• Essay — Science, Technology and Society
• GS4 — Dimensions of ethics - private and public relationships
• Prelims_GS — Biology and Health
• GS4 — Essence, determinants and consequences of Ethics in human actions
• Essay — Philosophy, Ethics and Human Values
• GS1 — Poverty and Developmental Issues
• Prelims_GS — Sustainable Development and Inclusion

Mains Angle

In a Mains answer, candidates can analyse the 2026 settlement as a catalyst for strengthening bio‑ethical regulations in India, linking it to Article 21 and recent ICMR guideline amendments. (GS4/GS3)